| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 3 |
| 1 | LEVOTHYROXINE SODIUM | 3 |
| 2 | TACROLIMUS | 3 |
| 3 | ACETAMINOPHEN | 2 |
| 4 | ACETAMINOPHEN 500MG | 2 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 6 | DOCUSATE SODIUM | 2 |
| 7 | DOCUSATE SODIUM 100MG | 2 |
| 8 | ESZOPICLONE | 2 |
| 9 | METHOTREXATE SODIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEOMYCIN SULFATE | 1 | 0.0004 |
| 1 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 2 | BECLOMETHASONE DIPROPIONATE | 1 | 0.0002 |
| 3 | MICAFUNGIN SODIUM | 1 | 0.0002 |
| 4 | TEDUGLUTIDE | 2 | 0.0001 |
| 5 | DAPTOMYCIN | 1 | 0.0001 |
| 6 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 1 | 0.0001 |
| 7 | CHOLESTYRAMINE | 1 | 0.0001 |
| 8 | GOLIMUMAB | 1 | 0.0001 |
| 9 | ESZOPICLONE | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 5 |
| 1 | Corticosteroid [EPC] | 3 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 |
| 3 | Benzodiazepine [EPC] | 2 |
| 4 | GLP-2 Analog [EPC] | 2 |
| 5 | Integrin Receptor Antagonist [EPC] | 2 |
| 6 | Phenothiazine [EPC] | 2 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 2 |
| 8 | Alkylating Drug [EPC] | 1 |
| 9 | Aluminum Complex [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 1 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 2 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 3 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 4 | Phenothiazine [EPC] | 2 | 0.0001 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Bile Acid [EPC] | 1 | 0.0000 |
| 7 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Soluble Guanylate Cyclase Stimulator [EPC] | 1 | 0.0000 |